Department of Pediatrics- Immunohematology and Stem Cell Transplantation, National Center of Bone Marrow Transplant, 02 Street Jbel Lakhdhar, Bab Saadoun, Tunis, Tunisia.
Faculty of Medicine, University of Tunis El Manar, Tunis, Tunisia.
Int Orthop. 2023 Dec;47(12):2941-2952. doi: 10.1007/s00264-023-05886-8. Epub 2023 Jul 15.
Osteonecrosis of the femoral head (ONFH) is a degenerative and progressive disorder that mainly affects people with sickle cell disease (SCD). Herein, we aimed to search for a better understanding of markers that can act as risk factors for ONFH in patients with SCD.
We conducted a retrospective study including 510 SCD patients followed over 23 years. Patients were divided into the ONFH group and the no-ONHF control group. Univariate and multivariate logistic regression analyses were performed to identify risk factors.
Among 510 SCD patients, 41(8%) were diagnosed with ONFH at a mean age of 167 months ± 64 (72-288). The cumulative incidence of ONHF increased from 2.3% at ten years to 18.3% at 20 years of age. The radiological grade 3 ONHF was predominant. No significant differences in sex, age at diagnosis of SCD, and Hb genotype were found between groups. The patient age and the time since diagnosis of SCD were statistically higher in patients with ONHF in univariate and multivariate analysis. ONHF was also associated with higher creatinine level (p = 0.001) lower LDH level (p = 0.006), and higher number of vaso-occlusive crisis (VOC)/patient/year (p < 0.001). The cumulative incidence of ONHF in patients having more than 3 VOC/year was significantly higher (43% versus 18.9% at 20 years, p < 0.001). In addition, infections, gallstones, growth delay, delayed initiation of hydroxyurea, and a higher transfusion rate were significantly associated with ONFH.
These findings confirm that ONFH is closely related to the age, severity, and duration of SCD. Better management of this disease prevents acute and chronic complications, and early screening of the ONFH as soon as the first signs of the severity of the disease are detected provides a better functional prognosis.
股骨头坏死(ONFH)是一种退行性和进行性疾病,主要影响镰状细胞病(SCD)患者。在此,我们旨在寻找更好地了解可作为 SCD 患者 ONFH 风险因素的标志物。
我们进行了一项回顾性研究,纳入了 510 例 SCD 患者,随访时间超过 23 年。患者分为 ONFH 组和无 ONHF 对照组。采用单变量和多变量逻辑回归分析来确定危险因素。
在 510 例 SCD 患者中,41 例(8%)被诊断为 ONFH,平均年龄为 167 个月±64(72-288)。ONHF 的累积发病率从 10 年时的 2.3%增加到 20 年时的 18.3%。放射学 3 级 ONHF 更为常见。两组间的性别、SCD 诊断时的年龄和 Hb 基因型无显著差异。单变量和多变量分析显示,ONHF 患者的年龄和 SCD 诊断后时间均较高。ONHF 还与更高的肌酐水平(p=0.001)、更低的 LDH 水平(p=0.006)和更高的每年血管阻塞性危象(VOC)/患者数(p<0.001)相关。每年发生超过 3 次 VOC 的患者的 ONHF 累积发生率明显更高(20 年时分别为 43%和 18.9%,p<0.001)。此外,感染、胆石症、生长迟缓、羟基脲起始延迟和更高的输血率与 ONFH 显著相关。
这些发现证实 ONFH 与 SCD 的年龄、严重程度和持续时间密切相关。更好地管理这种疾病可以预防急性和慢性并发症,并且一旦发现疾病严重程度的最初迹象,就对 ONFH 进行早期筛查,可提供更好的功能预后。